{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:32:30Z","timestamp":1788827550304,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172866"],"award-info":[{"award-number":["82172866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373424"],"award-info":[{"award-number":["82373424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-12105-y","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:53:07Z","timestamp":1761936787000},"page":"2764-2777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated nomogram for predicting intracranial progression-free survival with EGFR-TKI combined with cranial radiotherapy: a multicenter study"],"prefix":"10.1007","volume":"36","author":[{"given":"Haoran","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3051-2146","authenticated-orcid":false,"given":"Ligang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"12105_CR1","doi-asserted-by":"publisher","first-page":"101058","DOI":"10.1016\/j.adro.2022.101058","volume":"8","author":"JC Farris","year":"2023","unstructured":"Farris JC, Hughes RT, Razavian NB et al (2023) Brain metastasis incidence and patterns of presentation after definitive treatment of locally advanced non-small cell lung cancer: a potential argument for brain magnetic resonance imaging surveillance. Adv Radiat Oncol 8:101058. https:\/\/doi.org\/10.1016\/j.adro.2022.101058","journal-title":"Adv Radiat Oncol"},{"key":"12105_CR2","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1016\/j.cllc.2018.01.007","volume":"19","author":"SN Waqar","year":"2018","unstructured":"Waqar SN, Samson PP, Robinson CG et al (2018) Non\u2013small-cell lung cancer with brain metastasis at presentation. Clin Lung Cancer 19:e373\u2013e379. https:\/\/doi.org\/10.1016\/j.cllc.2018.01.007","journal-title":"Clin Lung Cancer"},{"key":"12105_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40793-x","volume":"14","author":"A Skakodub","year":"2023","unstructured":"Skakodub A, Walch H, Tringale KR et al (2023) Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Nat Commun 14:4980. https:\/\/doi.org\/10.1038\/s41467-023-40793-x","journal-title":"Nat Commun"},{"key":"12105_CR4","doi-asserted-by":"publisher","first-page":"107540","DOI":"10.1016\/j.lungcan.2024.107540","volume":"191","author":"T Tozuka","year":"2024","unstructured":"Tozuka T, Noro R, Mizutani H et al (2024) Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-mutant non-small cell lung cancer. Lung Cancer 191:107540. https:\/\/doi.org\/10.1016\/j.lungcan.2024.107540","journal-title":"Lung Cancer"},{"key":"12105_CR5","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1200\/JCO.21.02641","volume":"40","author":"S Lu","year":"2022","unstructured":"Lu S, Dong X, Jian H et al (2022) AENEAS: a randomized phase III trial of aumolertinib versus gefitinib as first-line therapy for locally advanced or metastatic non\u2013small-cell lung cancer with EGFR Exon 19 deletion or L858R mutations. J Clin Oncol 40:3162\u20133171. https:\/\/doi.org\/10.1200\/JCO.21.02641","journal-title":"J Clin Oncol"},{"key":"12105_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jamaoncol.2023.5456","volume":"10","author":"TW Chen","year":"2024","unstructured":"Chen TW, Dai MS, Tseng LM et al (2024) Whole-brain radiotherapy alone vs preceded by bevacizumab, etoposide, and cisplatin for untreated brain metastases from breast cancer: a randomized clinical trial. JAMA Oncol 10:325\u2013334. https:\/\/doi.org\/10.1001\/jamaoncol.2023.5456","journal-title":"JAMA Oncol"},{"key":"12105_CR7","doi-asserted-by":"publisher","unstructured":"Dong X, Wang K, Yang H et al (2023) Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous integrated boost or stereotactic radiosurgery. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1220047","DOI":"10.3389\/fonc.2023.1220047"},{"key":"12105_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10585-025-10334-5","volume":"42","author":"L Kretzschmar","year":"2025","unstructured":"Kretzschmar L, Gabrys H, Joye A, Kraft J, Guckenberger M, Andratschke N (2025) Postoperative stereotactic radiosurgery (SRS) vs hypofractionated stereotactic radiotherapy (SRT) for resected brain metastases\u2014a single centre analysis. Clin Exp Metastasis 42:16. https:\/\/doi.org\/10.1007\/s10585-025-10334-5","journal-title":"Clin Exp Metastasis"},{"key":"12105_CR9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/ijc.33904","volume":"150","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Li S, Yang X et al (2022) Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasis. Int J Cancer 150:1318\u20131328. https:\/\/doi.org\/10.1002\/ijc.33904","journal-title":"Int J Cancer"},{"key":"12105_CR10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1200\/JCO.2016.69.7144","volume":"35","author":"WJ Magnuson","year":"2017","unstructured":"Magnuson WJ, Lester-Coll NH, Wu AJ et al (2017) Management of brain metastases in tyrosine kinase inhibitor\u2013na\u00efve epidermal growth factor receptor\u2013mutant non\u2013small-cell lung cancer: a retrospective multi-institutional analysis. J Clin Oncol 35:1070\u20131077. https:\/\/doi.org\/10.1200\/JCO.2016.69.7144","journal-title":"J Clin Oncol"},{"key":"12105_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jtho.2024.11.027","volume":"20","author":"Y Xia","year":"2025","unstructured":"Xia Y, Wang K, Zhao J et al (2025) Receptor tyrosine kinase fusion-mediated resistance to EGFR TKI in EGFR-mutant NSCLC: a multi-center analysis and literature review. J Thorac Oncol 20:465\u2013474. https:\/\/doi.org\/10.1016\/j.jtho.2024.11.027","journal-title":"J Thorac Oncol"},{"key":"12105_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11548-0","volume":"23","author":"Y Song","year":"2023","unstructured":"Song Y, Lin S, Chen J, Dang J (2023) First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis. BMC Cancer 23:1043. https:\/\/doi.org\/10.1186\/s12885-023-11548-0","journal-title":"BMC Cancer"},{"key":"12105_CR13","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1007\/s00330-015-4202-5","volume":"26","author":"ZL Yang","year":"2016","unstructured":"Yang ZL, Zhang LJ (2016) PET\/MRI of central nervous system: current status and future perspective. Eur Radiol 26:3534\u20133541. https:\/\/doi.org\/10.1007\/s00330-015-4202-5","journal-title":"Eur Radiol"},{"key":"12105_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. https:\/\/doi.org\/10.1038\/ncomms5006","journal-title":"Nat Commun"},{"key":"12105_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","volume":"3","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Yang TJ, Beal K et al (2017) Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA). JAMA Oncol 3:827. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3834","journal-title":"JAMA Oncol"},{"key":"12105_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ctrv.2018.10.011","volume":"71","author":"A Wrona","year":"2018","unstructured":"Wrona A, Dziadziuszko R, Jassem J (2018) Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors. Cancer Treat Rev 71:59\u201367. https:\/\/doi.org\/10.1016\/j.ctrv.2018.10.011","journal-title":"Cancer Treat Rev"},{"key":"12105_CR17","doi-asserted-by":"publisher","first-page":"105464","DOI":"10.1016\/j.ijmedinf.2024.105464","volume":"188","author":"RO Alabi","year":"2024","unstructured":"Alabi RO, Elmusrati M, Leivo I et al (2024) Artificial intelligence-driven radiomics in head and neck cancer: current status and future prospects. Int J Med Inform 188:105464. https:\/\/doi.org\/10.1016\/j.ijmedinf.2024.105464","journal-title":"Int J Med Inform"},{"key":"12105_CR18","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ et al (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16:e173\u2013e180. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7","journal-title":"Lancet Oncol"},{"key":"12105_CR19","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594. https:\/\/doi.org\/10.1136\/bmj.g7594","journal-title":"BMJ"},{"key":"12105_CR20","doi-asserted-by":"publisher","unstructured":"Kuai L, Zhang Y, Luo Y et al (2021) Prognostic nomogram for liver metastatic colon cancer based on histological type, tumor differentiation, and tumor deposit: a TRIPOD compliant large-scale survival study. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.604882","DOI":"10.3389\/fonc.2021.604882"},{"key":"12105_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.radonc.2022.06.010","volume":"174","author":"J Gong","year":"2022","unstructured":"Gong J, Zhang W, Huang W et al (2022) CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: a multicenter study. Radiother Oncol 174:8\u201315. https:\/\/doi.org\/10.1016\/j.radonc.2022.06.010","journal-title":"Radiother Oncol"},{"key":"12105_CR22","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1245\/s10434-024-15760-5","volume":"31","author":"M \u015eam \u00d6zdemir","year":"2024","unstructured":"\u015eam \u00d6zdemir M, Azamat S, \u00d6zdemir H et al (2024) Preoperative prediction of muscle invasiveness in bladder cancer: the role of 3D volumetric radiomics using diffusion-weighted MRI, the VI-RADS score, or a combination of both. Ann Surg Oncol 31:5845\u20135850. https:\/\/doi.org\/10.1245\/s10434-024-15760-5","journal-title":"Ann Surg Oncol"},{"key":"12105_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13244-023-01575-7","volume":"15","author":"A Demircio\u011flu","year":"2024","unstructured":"Demircio\u011flu A (2024) The effect of feature normalization methods in radiomics. Insights Imaging 15:2. https:\/\/doi.org\/10.1186\/s13244-023-01575-7","journal-title":"Insights Imaging"},{"key":"12105_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jtho.2024.09.1431","volume":"20","author":"HJ Li","year":"2025","unstructured":"Li HJ, Qiu ZB, Wang MM et al (2025) Radiomics-based support vector machine distinguishes molecular events driving the progression of lung adenocarcinoma. J Thorac Oncol 20:52\u201364. https:\/\/doi.org\/10.1016\/j.jtho.2024.09.1431","journal-title":"J Thorac Oncol"},{"key":"12105_CR25","doi-asserted-by":"publisher","unstructured":"Schniering J, Maciukiewicz M, Gabrys HS et al (2022) Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.04503-2020","DOI":"10.1183\/13993003.04503-2020"},{"key":"12105_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/10937404.2018.1490128","volume":"21","author":"JD Pleil","year":"2018","unstructured":"Pleil JD, Wallace MAG, Stiegel MA, Funk WE (2018) Human biomarker interpretation: the importance of intra-class correlation coefficients (ICC) and their calculations based on mixed models, ANOVA, and variance estimates. J Toxicol Environ Health B Crit Rev 21:161\u2013180. https:\/\/doi.org\/10.1080\/10937404.2018.1490128","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"12105_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/thorax-2023-220226","volume":"79","author":"MT Warkentin","year":"2024","unstructured":"Warkentin MT, Al-Sawaihey H, Lam S et al (2024) Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches. Thorax 79:307\u2013315. https:\/\/doi.org\/10.1136\/thorax-2023-220226","journal-title":"Thorax"},{"key":"12105_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1109\/TPAMI.2022.3145392","volume":"45","author":"AM Carrington","year":"2023","unstructured":"Carrington AM, Manuel DG, Fieguth PW et al (2023) Deep ROC analysis and AUC as balanced average accuracy, for improved classifier selection, audit and explanation. IEEE Trans Pattern Anal Mach Intell 45:329\u2013341. https:\/\/doi.org\/10.1109\/TPAMI.2022.3145392","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"12105_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","volume":"16","author":"DW Hosmer","year":"1997","unstructured":"Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S (1997) A comparison of goodness-of-fit tests for the logistic regression model. Statist Med 16:965\u2013980","journal-title":"Statist Med"},{"key":"12105_CR30","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell","year":"1982","unstructured":"Harrell FE, Califf RM (1982) Evaluating the yield of medical tests. JAMA 247:2543\u20132546","journal-title":"JAMA"},{"key":"12105_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26:565\u2013574. https:\/\/doi.org\/10.1177\/0272989X06295361","journal-title":"Med Decis Making"},{"key":"12105_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12121-z","volume":"24","author":"H Qi","year":"2024","unstructured":"Qi H, Hou Y, Zheng Z et al (2024) Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases. BMC Cancer 24:362. https:\/\/doi.org\/10.1186\/s12885-024-12121-z","journal-title":"BMC Cancer"},{"key":"12105_CR33","doi-asserted-by":"publisher","first-page":"110334","DOI":"10.1016\/j.radonc.2024.110334","volume":"197","author":"M Zeng","year":"2024","unstructured":"Zeng M, Verma V, Chen X et al (2024) Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: Results & reflections from the prematurely closed phase III HYBRID trial. Radiother Oncol 197:110334. https:\/\/doi.org\/10.1016\/j.radonc.2024.110334","journal-title":"Radiother Oncol"},{"key":"12105_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-023-02389-z","volume":"18","author":"I Gruber","year":"2023","unstructured":"Gruber I, Weidner K, Treutwein M, Koelbl O (2023) Stereotactic radiosurgery of brain metastases: a retrospective study. Radiat Oncol 18:202. https:\/\/doi.org\/10.1186\/s13014-023-02389-z","journal-title":"Radiat Oncol"},{"key":"12105_CR35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jamaoncol.2021.1262","volume":"7","author":"WC Chen","year":"2021","unstructured":"Chen WC, Baal UH, Baal JD et al (2021) Efficacy and safety of stereotactic radiosurgery for brainstem metastases: a systematic review and meta-analysis. JAMA Oncol 7:1033\u20131040. https:\/\/doi.org\/10.1001\/jamaoncol.2021.1262","journal-title":"JAMA Oncol"},{"key":"12105_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","volume":"36","author":"PD Brown","year":"2018","unstructured":"Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V (2018) Whole-brain radiotherapy for brain metastases: evolution or revolution?. J Clin Oncol 36:483\u2013491. https:\/\/doi.org\/10.1200\/JCO.2017.75.9589","journal-title":"J Clin Oncol"},{"key":"12105_CR37","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483\u20132491. https:\/\/doi.org\/10.1001\/jama.295.21.2483","journal-title":"JAMA"},{"key":"12105_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11718-0","volume":"23","author":"J Bai","year":"2023","unstructured":"Bai J, He M, Gao E et al (2023) Radiomic texture analysis based on neurite orientation dispersion and density imaging to differentiate glioblastoma from solitary brain metastasis. BMC Cancer 23:1231. https:\/\/doi.org\/10.1186\/s12885-023-11718-0","journal-title":"BMC Cancer"},{"key":"12105_CR39","doi-asserted-by":"publisher","first-page":"110405","DOI":"10.1016\/j.radonc.2024.110405","volume":"198","author":"JA Crouzen","year":"2024","unstructured":"Crouzen JA, Mast ME, Hakstege M et al (2024) External validation of the lung-molGPA to predict survival in patients treated with stereotactic radiotherapy for brain metastases of non-small cell lung cancer. Radiother Oncol 198:110405. https:\/\/doi.org\/10.1016\/j.radonc.2024.110405","journal-title":"Radiother Oncol"},{"key":"12105_CR40","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1007\/s00259-021-05371-7","volume":"48","author":"M Kirienko","year":"2021","unstructured":"Kirienko M, Sollini M, Corbetta M et al (2021) Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer. Eur J Nucl Med Mol Imaging 48:3643\u20133655. https:\/\/doi.org\/10.1007\/s00259-021-05371-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12105_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11547-023-01617-6","volume":"128","author":"LL Shen","year":"2023","unstructured":"Shen LL, Zheng HL, Ding FH et al (2023) Delta computed tomography radiomics features-based nomogram predicts long-term efficacy after neoadjuvant chemotherapy in advanced gastric cancer. Radiol Med 128:402\u2013414. https:\/\/doi.org\/10.1007\/s11547-023-01617-6","journal-title":"Radiol Med"},{"key":"12105_CR42","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.3390\/cancers15071968","volume":"15","author":"F Cousin","year":"2023","unstructured":"Cousin F, Louis T, Dheur S et al (2023) Radiomics and delta-radiomics signatures to predict response and survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors. Cancers (Basel) 15:1968. https:\/\/doi.org\/10.3390\/cancers15071968","journal-title":"Cancers (Basel)"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-12105-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:19:25Z","timestamp":1774883965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-12105-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["12105"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-12105-y","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Ligang Xing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board because of the retrospective design.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The Institutional Review Board and Ethics Committee of Shandong Cancer Hospital have confirmed that no ethical approval is required (Approval No. 2021007018).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}